Dr. Björn Meijers is professor of Medicine at KU Leuven University Hospital. He received his M.D. at KU Leuven in 2002. His clinical training included stays in Belgium, Scotland and the Netherlands. His research interests include biomarker research, the pathophysiology of advanced chronic kidney disease, as well as the management of end-stage kidney disease by renal replacement therapy.

He has experience with both investigator-driven and company-driven clinical research, both early phase (phase I and phase II), as well as phase III and phase IV research. He also coordinates a translational research team focused on the role of the gut in the pathophysiology of chronic kidney disease. He has been awarded funding as fundamental-clinical researcher by FWO-flanders, and participates in H2020 innovative training networks.

Dr. Meijers serves as board member of the nephrology educational portal of the European Renal Association, and is (associate) editor of several scientific journals including Toxins and BMC nephrology. He has (co-)authored more than 150 scientific articles, with more than 5000 citations to date, resulting in a current H-index of 41.